Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The acute toxicity of 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline has been studied in the rat for the oral and dermal routes. No information about the acute inhalation toxicity of 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline is available.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Acute toxicity: via dermal route

Endpoint conclusion
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Additional information

Both, the oral and dermal acute toxicity studies performed with 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline found LD50 values that were greater than 2000 mg/kg body weight indicating that the substance exhibits low acute toxicity to the rat. Clinical signs including piloerection and depressed body weight gain show that 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline is at least partly systemically available via the oral route and that high volume of the substance may exhibit a certain systemic toxicity. It appears that the availability via the dermal route is negligible.

Justification for classification or non-classification

The substance is not classified as acute toxic by EU-GHS (CLP), since LD50 > 2000 mg/ kg body weight, which is the cut-off in the EU's GHS classification system for acute oral and dermal toxicity.

UN-GHS has a Category 5 for acute oral toxicity for the dose range 2000 mg/kg bw < LD50 < 5000 mg/kg bw, a concentration range which has not been tested. However acute toxicity Category 5 is applied by some authorities only. Furthermore, acc. to GHS 3.1.2.5 testing animals in the Category 5 range is discouraged unless "there is a strong likelyhood that results of such testing would have a direct relevance to the protection of human health", which is not the case.